SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-18-004374
Filing Date
2018-10-22
Accepted
2018-10-22 13:26:44
Documents
2
Period of Report
2018-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1757
2 meyers_poa.htm EX-24.1 11465
  Complete submission text file 0001567619-18-004374.txt   14740
Mailing Address GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Meyers James R (Reporting) CIK: 0001387521 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 181132046

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations